Founded by Dr Huang Lequn, who studied in the United States, Sinobiopharma Inc is a foreign-funded enterprise registered in Nantong Economic and Technological Development Zone in 2004. The company's registered capital is $5 million, and the total investment is $10 million.

Sinobiopharma Inc is a fully integrated professional biological pharmaceutical company featuring production of innovative first generic drugs and branded medicine with patented technology. Its products benefit Chinese people with its integration of research, development, production and marketing. The anesthesia assistant and drugs for cardiovascular disease have entered most of China’s AAA hospitals, replacing imported drugs of the same kind. While winning market shares, Sinobiopharma Inc also shows strong development capacity and profitability. Its profit and tax is expected to exceed 30 million yuan this year.

Sinobiopharma Inc has 20,000 square meters of GMP manufacturing workshops which meet the requirements for SFDA certification and 6 certified GMP production lines including tablet, capsule, injection, granule, dry powder and raw material. The equipment scale is upgraded and expanded year on year so as to satisfy the increasing market demand.